AAAAAA
Results:
1-7
|
Results: 7
Authors:
Vandenbos, F
Baldin, B
Garraffo, R
Mondain-Miton, V
Dellamonica, P
Citation: F. Vandenbos et al., Agranulocytosis and seizure during prolonged ceftriaxone treatment, ANN MED IN, 152(3), 2001, pp. 215-216
Authors:
Caroli-Bose, FX
Iliadis, A
Salmon, L
Macheras, P
Montet, AM
Bourgeon, A
Garraffo, R
Delmont, JP
Montet, JC
Citation: Fx. Caroli-bose et al., Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients, FUN CL PHAR, 14(6), 2000, pp. 601-609
Authors:
Garraffo, R
Citation: R. Garraffo, Protease inhibitor resistance: role of the MDR gene, PRESSE MED, 29(37), 2000, pp. 2038-2039
Authors:
Clevenbergh, P
Durant, J
Garraffo, R
Chaillou, S
Cua, E
Dellamonica, P
Citation: P. Clevenbergh et al., Multiples aspects of VIH resistance to antiretroviral drugs., MED MAL INF, 30(9), 2000, pp. 551-564
Authors:
Lemercier, V
Tod, M
Garraffo, R
Petitjean, O
Citation: V. Lemercier et al., Pharmacokinetics and pharmacodynamics of valaciclovir and famciclovir., MED MAL INF, 30(7), 2000, pp. 455-467
Authors:
Durant, J
Clevenbergh, P
Garraffo, R
Halfon, P
Icard, S
Del Giudice, P
Montagne, N
Schapiro, JM
Dellamonica, P
Citation: J. Durant et al., Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the ViradaptStudy, AIDS, 14(10), 2000, pp. 1333-1339
Authors:
Chaillou, S
Durant, J
Clevenbergh, P
Rahelinirina, V
Garraffo, R
Schapiro, JM
Dellamonica, P
Citation: S. Chaillou et al., Long term effectiveness of Saquinavir and Ritonavir low dosage (baby-dose)in HIV patients failing combination therapy: correlation of response to treatment with genotype mutations and pharmacological data, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 69-72
Risultati:
1-7
|